$HNOI
HNO International, Inc.

2024 Q3 Form 10-Q Financial Statement

#000126246324000084 Filed on September 20, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2023 Q3
Revenue $4.241K $0.00
YoY Change -100.0%
Cost Of Revenue $3.688K $0.00
YoY Change
Gross Profit $553.00 $0.00
YoY Change -100.0%
Gross Profit Margin 13.04%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $490.3K $460.8K
YoY Change 6.39% 18.83%
Operating Profit -$496.6K -$459.8K
YoY Change 8.01% 24.09%
Interest Expense $7.227K
YoY Change 55.65%
% of Operating Profit
Other Income/Expense, Net -$6.924K $996.00
YoY Change -795.18% 3730.77%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$496.6K -$459.8K
YoY Change 8.01% 24.09%
Net Earnings / Revenue -11710.0%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 410.6M shares 191.6M shares
Diluted Shares Outstanding 410.6M shares 191.6M shares

Balance Sheet

Concept 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $78.92K $1.227M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $78.92K $1.283M
YoY Change -93.85%
LONG-TERM ASSETS
Property, Plant & Equipment $993.6K $378.3K
YoY Change 162.63%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $129.9K $29.25K
YoY Change 344.06%
Total Long-Term Assets $1.336M $487.9K
YoY Change 173.72%
TOTAL ASSETS
Total Short-Term Assets $78.92K $1.283M
Total Long-Term Assets $1.336M $487.9K
Total Assets $1.414M $1.771M
YoY Change -20.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $22.05K $925.00
YoY Change 2284.0%
Accrued Expenses $61.91K $34.34K
YoY Change 80.32%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.729M $884.9K
YoY Change 95.33%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $670.7K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.729M $884.9K
Total Long-Term Liabilities $670.7K
Total Liabilities $2.399M $1.475M
YoY Change 62.67%
SHAREHOLDERS EQUITY
Retained Earnings -$43.19M -$41.13M
YoY Change 5.02%
Common Stock $42.20M $41.42M
YoY Change 1.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$984.7K $296.1K
YoY Change
Total Liabilities & Shareholders Equity $1.414M $1.771M
YoY Change -20.13%

Cashflow Statement

Concept 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$496.6K -$459.8K
YoY Change 8.01% 24.09%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-31
dei Entity Central Index Key
EntityCentralIndexKey
0001342916
dei Document Type
DocumentType
10-Q
CY2023Q4 hnoi Due From Related Party
DueFromRelatedParty
56392 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
291551 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
767938 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
79324 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
103821 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 usd
CY2023Q4 us-gaap Security Deposit
SecurityDeposit
100000 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1051083 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
925 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
41270 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
17640 usd
CY2023Q4 hnoi Advances Related Party
AdvancesRelatedParty
0 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
985000000 shares
CY2023Q3 us-gaap Revenues
Revenues
0 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
-0 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
553 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
0 usd
CY2024Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
9593 usd
CY2023Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
0 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
430693 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
437472 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
49964 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
16103 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
490250 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
453575 usd
CY2024Q3 us-gaap Interest Income Other
InterestIncomeOther
7 usd
CY2024Q3 us-gaap Interest Expense Other
InterestExpenseOther
6931 usd
CY2023Q3 us-gaap Interest Expense Other
InterestExpenseOther
7227 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6924 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6231 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-496621 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-459806 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-496621 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-459806 usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q3 hnoi Shares Cancelled As Per Settlement Agreement Vivaris Capital
SharesCancelledAsPerSettlementAgreementVivarisCapital
usd
CY2023Q2 hnoi Regulation D Stock Issuances
RegulationDStockIssuances
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-07-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56568
dei Entity Registrant Name
EntityRegistrantName
HNO INTERNATIONAL, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-2781289
dei Entity Address Address Line1
EntityAddressAddressLine1
41558 Eastman Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite B
dei Entity Address City Or Town
EntityAddressCityOrTown
Murrieta
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92562
dei City Area Code
CityAreaCode
951
dei Local Phone Number
LocalPhoneNumber
305-8872
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
417087865 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78917 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
235159 usd
CY2024Q3 hnoi Due From Related Party
DueFromRelatedParty
0 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
78917 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
993578 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
76236 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
129889 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
135875 usd
CY2024Q3 us-gaap Security Deposit
SecurityDeposit
0 usd
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
1335578 usd
CY2024Q3 us-gaap Assets
Assets
1414495 usd
CY2023Q4 us-gaap Assets
Assets
1342634 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
22052 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
61913 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
56051 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2838 usd
CY2024Q3 hnoi Advances Related Party
AdvancesRelatedParty
800585 usd
CY2024Q3 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
99 usd
CY2023Q4 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
0 usd
CY2024Q3 hnoi Notes Payable Related Party Current
NotesPayableRelatedPartyCurrent
785000 usd
CY2023Q4 hnoi Notes Payable Related Party Current
NotesPayableRelatedPartyCurrent
785000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1728538 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
844835 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
80668 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2024Q3 hnoi Long Term Notes Payable Related Party
LongTermNotesPayableRelatedParty
590000 usd
CY2023Q4 hnoi Long Term Notes Payable Related Party
LongTermNotesPayableRelatedParty
590000 usd
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
670668 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
590000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
2399206 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1434835 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
985000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
410739392 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
410739392 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
419341584 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
419341584 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
410739 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
419341 usd
CY2024Q3 hnoi Common Stock Payable
CommonStockPayable
17750 usd
CY2023Q4 hnoi Common Stock Payable
CommonStockPayable
32251 usd
CY2024Q3 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
13750 usd
CY2023Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
23750 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
41784933 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
41079902 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43194383 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41609945 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-984711 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-92201 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1414495 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1342634 usd
CY2024Q3 us-gaap Revenues
Revenues
4241 usd
us-gaap Revenues
Revenues
4241 usd
us-gaap Revenues
Revenues
13000 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
3688 usd
us-gaap Cost Of Revenue
CostOfRevenue
3688 usd
us-gaap Cost Of Revenue
CostOfRevenue
5885 usd
us-gaap Gross Profit
GrossProfit
553 usd
us-gaap Gross Profit
GrossProfit
7115 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
9593 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
3000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1440197 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
927082 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
120056 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
20450 usd
us-gaap Operating Expenses
OperatingExpenses
1569846 usd
us-gaap Operating Expenses
OperatingExpenses
950532 usd
CY2023Q3 us-gaap Interest Income Other
InterestIncomeOther
996 usd
us-gaap Interest Income Other
InterestIncomeOther
5499 usd
us-gaap Interest Income Other
InterestIncomeOther
1000 usd
us-gaap Interest Expense Other
InterestExpenseOther
20644 usd
us-gaap Interest Expense Other
InterestExpenseOther
19611 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-15145 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-18611 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1584438 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-962028 usd
us-gaap Net Income Loss
NetIncomeLoss
-1584438 usd
us-gaap Net Income Loss
NetIncomeLoss
-962028 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
410591730 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
410591730 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
414622749 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
414622749 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
416515952 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
416515952 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
329924011 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
329924011 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-92201 usd
CY2024Q1 hnoi Regulation Stock Issuances
RegulationStockIssuances
125500 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-522784 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-489485 usd
CY2024Q2 hnoi Regulation Stock Issuances
RegulationStockIssuances
133650 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-565033 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-920868 usd
CY2024Q3 hnoi Regulation Stock Issuances
RegulationStockIssuances
157278 usd
CY2024Q3 hnoi Regulation D Stock Issuances
RegulationDStockIssuances
275500 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-496621 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-984711 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1110425 usd
CY2023Q1 hnoi Regulation D Stock Issuances
RegulationDStockIssuances
182000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
2025 usd
CY2023Q1 hnoi Common Stock Issued For Settlement Of Debt
CommonStockIssuedForSettlementOfDebt
20000 usd
CY2023Q1 hnoi Common Stock To Be Issued From Reg D Cash Proceeds
CommonStockToBeIssuedFromRegDCashProceeds
100000 usd
CY2023Q1 hnoi Series Preferred Issued Pursuant To Patent Agreement
SeriesPreferredIssuedPursuantToPatentAgreement
82500 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-204373 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-928273 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-297848 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1226121 usd
CY2023Q3 hnoi Regulation D Stock Issuances
RegulationDStockIssuances
8000 usd
CY2023Q3 hnoi Regulation Stock Issuances
RegulationStockIssuances
1974032 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-459806 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
296105 usd
us-gaap Profit Loss
ProfitLoss
-1584438 usd
us-gaap Profit Loss
ProfitLoss
-962028 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
120056 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
20450 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
2025 usd
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-56392 usd
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
21127 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
925 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
20643 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
19610 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
844 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-14802 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
14653 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1380178 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-904365 usd
hnoi Proceeds From Related Party Advances
ProceedsFromRelatedPartyAdvances
800585 usd
hnoi Proceeds From Related Party Advances
ProceedsFromRelatedPartyAdvances
0 usd
hnoi Proceeds From Related Party Note Payable
ProceedsFromRelatedPartyNotePayable
0 usd
hnoi Proceeds From Related Party Note Payable
ProceedsFromRelatedPartyNotePayable
250000 usd
us-gaap Proceeds From Other Deposits
ProceedsFromOtherDeposits
100000 usd
us-gaap Proceeds From Other Deposits
ProceedsFromOtherDeposits
6800 usd
hnoi Proceeds From Customer Deposits
ProceedsFromCustomerDeposits
99 usd
hnoi Proceeds From Customer Deposits
ProceedsFromCustomerDeposits
0 usd
hnoi Proceeds From Sale Of Common Stock Subscription Payable
ProceedsFromSaleOfCommonStockSubscriptionPayable
-14501 usd
hnoi Proceeds From Sale Of Common Stock Subscription Payable
ProceedsFromSaleOfCommonStockSubscriptionPayable
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
706429 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2264032 usd
hnoi Repayment Of Related Party Note Payables
RepaymentOfRelatedPartyNotePayables
-0 usd
hnoi Repayment Of Related Party Note Payables
RepaymentOfRelatedPartyNotePayables
15000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1592612 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2505832 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
335772 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
396630 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
32904 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
29250 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-368676 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-425880 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-156242 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1175587 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
235159 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51109 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78917 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1226696 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Stock Issued1
StockIssued1
0 usd
us-gaap Stock Issued1
StockIssued1
82500 usd
hnoi Cancellation Of Common Stock
CancellationOfCommonStock
-10000 usd
hnoi Cancellation Of Common Stock
CancellationOfCommonStock
0 usd
us-gaap Notes Assumed1
NotesAssumed1
0 usd
us-gaap Notes Assumed1
NotesAssumed1
20000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_845_eus-gaap--UseOfEstimates_zpFptl3iPZQi" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_86D_zmcyYzUFCU1g">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the condensed financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amount of revenues and expenses during the reporting period. The management makes its best estimate of the outcome for these items based on information available when the condensed financial statements are prepared.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
us-gaap Revenues
Revenues
4241 usd
us-gaap Revenues
Revenues
13000 usd
CY2024Q3 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P20Y
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_841_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zSWE3G2rOHfi" style="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86E_z0bpQhtAo6He">Reclassification of Prior Year Presentation</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Certain prior year amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43194383 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1140650 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
804878 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
147072 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
36940 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
993578 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
767938 usd
us-gaap Depreciation
Depreciation
110132 usd
us-gaap Depreciation
Depreciation
18314 usd
CY2024Q3 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P20Y
CY2024Q3 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
82500 usd
CY2023Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
82500 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6264 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3176 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
76236 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
79324 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3088 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2136 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
135875 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
136719 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
56051 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
80668 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y4M2D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0414 pure
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
15227 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
60909 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
65986 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
142122 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
985000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 hnoi Stock Issued During Period Regulation A Stock Issuances Shares
StockIssuedDuringPeriodRegulationAStockIssuancesShares
1968032 shares
CY2023Q3 hnoi Stock Issued During Period Regulation A Stock Issuance
StockIssuedDuringPeriodRegulationAStockIssuance
1968032 usd
CY2023Q3 hnoi Stock Issued During Period Regulation A Stock Receivable Shares
StockIssuedDuringPeriodRegulationAStockReceivableShares
13750 shares
CY2023Q3 hnoi Stock Issued During Period Regulation A Stock Receivable
StockIssuedDuringPeriodRegulationAStockReceivable
13750 usd
CY2023Q3 hnoi Sale Of Stock Payable Share
SaleOfStockPayableShare
19750 shares
CY2023Q3 hnoi Sale Of Stock Payables
SaleOfStockPayables
19750 usd
CY2023Q4 hnoi Stock Issued During Period Regulation A Stock Issuances Shares
StockIssuedDuringPeriodRegulationAStockIssuancesShares
52500 shares
CY2023Q4 hnoi Stock Issued During Period Regulation A Stock Issuance
StockIssuedDuringPeriodRegulationAStockIssuance
52500 usd
CY2023Q4 hnoi Stock Issued During Period Regulation A Stock Payable Shares
StockIssuedDuringPeriodRegulationAStockPayableShares
6000 shares
CY2023Q4 hnoi Sale Of Stock Payable Share
SaleOfStockPayableShare
18501 shares
CY2023Q4 hnoi Sale Of Stock Payables
SaleOfStockPayables
18501 usd
CY2024Q1 hnoi Stock Issued During Period Regulation A Stock Issuances Shares
StockIssuedDuringPeriodRegulationAStockIssuancesShares
74500 shares
CY2024Q1 hnoi Stock Issued During Period Regulation A Stock Issuance
StockIssuedDuringPeriodRegulationAStockIssuance
74500 usd
CY2024Q1 hnoi Stock Issued During Period Regulation A Stock Payable Shares
StockIssuedDuringPeriodRegulationAStockPayableShares
17001 shares
CY2024Q1 hnoi Sale Of Stock Payable Share
SaleOfStockPayableShare
51000 shares
CY2024Q1 hnoi Sale Of Stock Payables
SaleOfStockPayables
51000 usd
CY2024Q2 hnoi Stock Issued During Period Regulation A Stock Issuances Shares
StockIssuedDuringPeriodRegulationAStockIssuancesShares
64900 shares
CY2024Q2 hnoi Stock Issued During Period Regulation A Stock Issuance
StockIssuedDuringPeriodRegulationAStockIssuance
69400 usd
CY2024Q2 hnoi Stock Issued During Period Regulation A Stock Payable Shares
StockIssuedDuringPeriodRegulationAStockPayableShares
51000 shares
CY2024Q2 hnoi Sale Of Stock Payable Share
SaleOfStockPayableShare
64250 shares
CY2024Q2 hnoi Sale Of Stock Payables
SaleOfStockPayables
64250 usd
CY2024Q3 hnoi Stock Issued During Period Regulation A Stock Issuances Shares
StockIssuedDuringPeriodRegulationAStockIssuancesShares
158278 shares
CY2024Q3 hnoi Stock Issued During Period Regulation A Stock Issuance
StockIssuedDuringPeriodRegulationAStockIssuance
158278 usd
CY2024Q3 hnoi Stock Issued During Period Regulation A Stock Payable Shares
StockIssuedDuringPeriodRegulationAStockPayableShares
60750 shares
CY2024Q3 hnoi Sale Of Stock Payable Share
SaleOfStockPayableShare
1000 shares
CY2024Q3 hnoi Sale Of Stock Payables
SaleOfStockPayables
1000 usd
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
410739392 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
410739392 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
419341584 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
419341584 shares
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
1375000 usd
CY2023Q4 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
1375000 usd
CY2024Q3 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
61786 usd
CY2023Q4 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
41270 usd
CY2024Q1 hnoi Proceeds From Related Party
ProceedsFromRelatedParty
56392 usd
CY2023Q4 hnoi Proceeds From Related Party
ProceedsFromRelatedParty
56392 usd
CY2022Q4 hnoi Proceeds From Related Party
ProceedsFromRelatedParty
56392 usd
CY2024 us-gaap Related Party Transaction Terms And Manner Of Settlement
RelatedPartyTransactionTermsAndMannerOfSettlement
The settlement agreement involved the transfer of equipment, categorized into large and small equipment, with a combined value of $56,392. Specifically, large equipment was valued at $32,327, and small equipment at $24,065.
CY2024Q2 us-gaap Interest Receivable
InterestReceivable
5185 usd
CY2024Q2 us-gaap Financing Receivable Excluding Accrued Interest Nonaccrual Percent Past Due
FinancingReceivableExcludingAccruedInterestNonaccrualPercentPastDue
0.05 pure
CY2024Q3 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
5185 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001262463-24-000084-index-headers.html Edgar Link pending
0001262463-24-000084-index.html Edgar Link pending
0001262463-24-000084.txt Edgar Link pending
0001262463-24-000084-xbrl.zip Edgar Link pending
ex311.htm Edgar Link pending
ex312.htm Edgar Link pending
ex321.htm Edgar Link pending
ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hnoi-20240731.xsd Edgar Link pending
hnoi073124q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
hnoi-20240731_cal.xml Edgar Link unprocessable
hnoi-20240731_def.xml Edgar Link unprocessable
hnoi-20240731_lab.xml Edgar Link unprocessable
hnoi-20240731_pre.xml Edgar Link unprocessable
hnoi073124q_htm.xml Edgar Link completed
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending